HEALTHCARE & MEDICARE
-
Private equity's health care boom gets more crowded
Global private equity activity in the healthcare industry hit a new record last year, with deal value estimated at $191…
Read More » -
Surescripts partners with GoodRx to launch prescription price transparency tool
Health intelligence network Surescripts on Tuesday launched a new product called Script Corner aimed at increasing drug price transparency. The…
Read More » -
Learn about Medicare Part D and prescription drug coverage
This month, the Center for Medicare Rights, with support from the National Council on Aging, released a new series of…
Read More » -
Key components of enhanced outpatient program retention
Behavioral health providers are needed today more than ever, and treatment options are constantly being sought to support patients. Intensive…
Read More » -
MedCity Pivot Podcast: Assessing the hype and potential of AI in healthcare and the guardrails needed to prevent medical errors
In the latest episode of the MedCity Pivot Podcast, the discussion explores meaningful applications of artificial intelligence in healthcare. MedCity…
Read More » -
Jim Gallic Presents Wonderr Health – Healthcare Blog
health technology January 14, 2026 Jim Gallic is chief growth officer at Wonderr Health, a company specializing in the behavioral…
Read More » -
Fullscript and ŌURA partner to bring wearable data into clinical workflows
Fullscript has partnered with wearable device company ŌURA to bring its biometric insights into Fullscript's clinical workflows, the company announced…
Read More » -
From Scarcity to Possibility: What Perfusion Technology Means for the Organ Transplant Industry
Every transplant is a race against time. Once an organ leaves the body, its condition begins to deteriorate. Static cold…
Read More » -
What do medical practices hope to gain from revenue cycle management technology?
Adopting and implementing new technologies is a major undertaking for medical practices and hospitals. But a research report sponsored by…
Read More » -
AbbVie invests $650 million to join nascent but crowded cancer drug R&D field
AbbVie is diversifying its oncology pipeline, spending $650 million on a clinical-stage drug that targets two anti-cancer targets. It's the…
Read More »